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Abstract: MotionSense HRV is a wrist-worn accelerometery-based sensor that is paired with a 
smartphone and is thus capable of measuring the intensity, duration, and frequency of physical 
activity (PA). However, little information is available on the validity of the MotionSense HRV. 
Therefore, the purpose of this study was to assess the concurrent validity of the MotionSense HRV 
in estimating sedentary behavior (SED) and PA. A total of 20 healthy adults (age: 32.5 ± 15.1 years) 
wore the MotionSense HRV and ActiGraph GT9X accelerometer (GT9X) on their non-dominant 
wrist for seven consecutive days during free-living conditions. Raw acceleration data from the de-
vices were summarized into average time (min/day) spent in SED and moderate-to-vigorous PA 
(MVPA). Additionally, using the Cosemed K5 indirect calorimetry system (K5) as a criterion meas-
ure, the validity of the MotionSense HRV was examined in simulated free-living conditions. Pear-
son correlations, mean absolute percent errors (MAPE), Bland–Altman (BA) plots, and equivalence 
tests were used to examine the validity of the MotionSense HRV against criterion measures. The 
correlations between the MotionSense HRV and GT9X were high and the MAPE were low for both 
the SED (r = 0.99, MAPE = 2.4%) and MVPA (r = 0.97, MAPE = 9.1%) estimates under free-living 
conditions. BA plots illustrated that there was no systematic bias between the MotionSense HRV 
and criterion measures. The estimates of SED and MVPA from the MotionSense HRV were signifi-
cantly equivalent to those from the GT9X; the equivalence zones were set at 16.5% for SED and 29% 
for MVPA. The estimates of SED and PA from the MotionSense HRV were less comparable when 
compared with those from the K5. The MotionSense HRV yielded comparable estimates for SED 
and PA when compared with the GT9X accelerometer under free-living conditions. We confirmed 
the promising application of the MotionSense HRV for monitoring PA patterns for practical and 
research purposes. 
Keywords: mobile health; sedentary behavior; physical activity; validity; MotionSense HRV;  
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With advances in mobile technology, the field of mobile health (mHealth) has at-
tracted the attention of healthcare providers interested in efficient patient care. The World 
Health Organization defines mHealth as the practice of public health and medicine sup-
ported by mobile devices such as smartphones.1 mHealth embodies a healthcare system 
that capitalizes on mobile devices' voice and text messaging service, wireless telecommu-
nications (e.g., LTE network), Bluetooth® technology, and global positioning system 
(GPS) [1]. mHealth technology allows for more people to connect with innovative health 
care services, including health care management, health care information on demand, and 
the real-time monitoring of behavior and chronic conditions. For instance, mHealth tech-
nology can efficiently and quickly support healthcare providers’ remote clinical care 
through the periodical or real-time monitoring of patients’ physiological factors (e.g., 
heart rate) and health-related behaviors (e.g., physical activity (PA)) [2–4]. Thus, advances 
in mHealth technology are expected to significantly improve the clinical and wellness care 
for various populations by reducing the cost and burden of the evaluation of risk factors 
of potential chronic disorders. 
The National Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) is 
a part of the Big Data-to-Knowledge program funded by the National Institutes of Health. 
An overarching goal of the MD2K is to use mobile sensor technologies to detect and pre-
dict behavioral, psychological, and environmental risk factors of specific diseases [5–6]. 
The ability to detect risk factors and prevent the emergence of adverse clinical events is 
an essential strategy in preventive medicine and can help to reduce health care costs [5–
7]. Recently, the MD2K developed an innovative multi-sensor approach named puff-
Maker to objectively track smoking episodes using two wearable sensors called Au-
toSense and MotionSense [8]. AutoSense is a chest-worn sensor suite that could measure 
breathing patterns [9–10]. MotionSense is a wrist-worn inertial sensor equipped with a 3-
axis accelerometer and a 3-axis gyroscope for detecting accelerations and movements of 
the arms [11]. The acceleration and angular motion data collected at wrists can be trans-
lated into the intensity and amount of wrist movements. In fact, the use of wrist-worn 
accelerometers for assessing PA is now widespread [12–13]. This suggests that the Mo-
tionSense has tremendous potential to be a device for monitoring PA if its concurrent va-
lidity is confirmed.  
Recently, the MD2K team released MotionSense HRV, an upgraded version of the 
MotionSense that additionally includes a multispectral photoplethysmography (PPG) 
sensor [14–15]. With the additional sensors, the MotionSense HRV is capable of measuring 
various physiological and behavioral variables, including smoking events, heart rates, eat-
ing episodes, cocaine use, and brushing teeth [5,8,14–15]. The MotionSense HRV is paired 
with a smartphone via Bluetooth Low Energy. It transfers raw data to the mCerbrum mo-
bile application, an open-source mobile software platform developed by MD2K that stores 
and processes the raw data to make real-time inferences about the user’s state using ma-
chine learning models that can be used to trigger interventions on the mobile phone [16] 
The mCerebrum application allows the MotionSense HRV to collect data at a high sam-
pling frequency (i.e., ≥70 million samples/day) and compute the data in real time. The use 
of the MotionSense HRV and mCerebrum enables researchers to monitor users’ physio-
logical (e.g., heart rate) and behavioral changes (e.g., levels of PA) [5,17].  
PA plays a critical role in reducing the risks of obesity, diabetes, cancer, and cardio-
vascular diseases [18], thus, the study of PA is becoming a top-priority area in public 
health and clinical research. However, due to the complexity and intermittent patterns of 
PA performed in daily life, accurately assessing an individual’s PA level through subjec-
tive measures (i.e., self-reported questionnaires) is particularly challenging as the meth-
ods are vulnerable to recall and social-desirable biases [19]. Accelerometry-based activity 
monitors have been widely accepted as devices that can objectively assess an individual’s 
PA levels in free-living conditions [20]. An accelerometer is a sensor that measures the 
acceleration of an object’s movement along its reference axes, thus the data it captures 
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reflects the intensity and frequency of movement [21]. MotionSense HRV's built-in accel-
erometer records accelerations relative to the input force oriented to multi-orthogonal 
planes of motion within distinct time intervals (i.e., epochs). Thus, it can be used to esti-
mate the intensity, duration, and frequency of bodily movements. This suggests that the 
MotionSense HRV can potentially be utilized to monitor users’ PA and other behavioral 
and clinical measures concurrently. This device can also provide such information to 
healthcare providers for enhanced counseling. Despite the great potential of MotionSense 
HRV in PA monitoring, the concurrent validity of MotionSense HRV in estimating a user's 
PA has not been systematically evaluated against previously established criterion 
measures. Establishing the validity of PA estimates is an essential step toward ensuring 
that MotionSense HRV can be used to monitor users’ PA patterns. Therefore, the purpose 
of this study was to assess the validity of MotionSense HRV for estimating time spent in 
sedentary behavior and PA against indirect calorimetry and a research-grade accelerom-
eter.  
2. Materials and Methods 
2.1. Design 
This cross-sectional study was conducted in both free-living and laboratory-based 
simulated free-living settings. Sedentary behavior commonly refers to activities that re-
quire very low energy expenditure (≤ 1.5 metabolic equivalents), and PA is defined as any 
bodily movement produced by the contraction of skeletal muscles that substantially in-
creases energy expenditure (> 1.5 metabolic equivalents). The estimated time spent in sed-
entary behavior and physical activities from MotionSense HRV was compared to two cri-
terion measures: (1) the ActiGraph GT9X accelerometer for a free-living condition; and (2) 
the Cosmed K5 portable indirect calorimetry system for simulated free-living conditions. 
2.2. Participants 
A convenient sample of 20 Pacific Islanders (10 Tongan Americans and 10 Samoan 
Americans; age range: 18–65 years) participated in this study. Pacific Islanders are a pop-
ulation group that suffers from disproportionately high burdens of obesity and its related 
health consequences, such as cardiovascular diseases, diabetes, and cancers [22–25]. Con-
sidering the potential utilization of the MotionSense HRV for obesity and cancer patients, 
we chose Pacific Islanders as our study participants. Participants were recruited via word 
of mouth, email, and flyers at the National Tongan American Society and the Queen Cen-
ter in Salt Lake City in Utah. The directors and community leaders at those centers collab-
orated on recruiting the eligible participants and the follow-up with the participants of 
this study. Participants who were able to (1) participate in PA without any functional im-
pairment, (2) use a smartphone, and (3) communicate in English (speak, read, and write) 
were eligible to participate in this study. Exclusion criteria included the following: (1) an-
yone with an implanted cardiac device, such as a pacemaker, (2) those who were physi-
cally unable to wear equipment and use a smartphone; (3) individuals who were pregnant 
or lactating; and (4) people with any unstable medical or psychiatric problems. The study 
protocols were approved by the University of Utah Institutional Review Board (IRB ap-
proval number: 00109145).  
2.3. Instruments 
2.3.1. MotionSense HRV 
The MotionSense HRV is a custom wrist-worn sensor developed by the MD2K. The 
MotionSense HRV includes a tri-axial accelerometer and tri-axial gyroscope, a multispec-
tral (red-, green-, infrared-light emitting diodes) PPG sensor, and a microcontroller [15]. 
The MotionSense HRV can track (1) hand gestures and arm movements through accel-
erometers and gyroscopes and (2) interbeat intervals from optical sensors for calculating 
heart rate variability [5]. Recently, the arm movement tracking of the MotionSense HRV 
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was used for the puffMarker model, which can detect the timing of a lapse in smoking 
cessation by tracking arm movements [8]. Additionally, the MotionSense HRV could po-
tentially be used to assess stress (i.e., cStress model) by integrating the measures of accel-
erations, interbeat intervals, and heart rate variability [26]. The data collected by the Mo-
tionSense HRV are transmitted to a smartphone in real time using the built-in microcon-
troller [15]. Given the evidence, the measures of time spent in sedentary behavior and PA 
as well as other health information by the MotionSense HRV in everyday life can poten-
tially provide several benefits: (1) the periodical or real-time detection of health-related 
risk factors such as excessive sedentary behavior; (2) the convenient self-monitoring of 
various health-related behaviors with a wrist-worn sensor and mobile application; (3) the 
real-time sharing of various types of health information with healthcare providers for ef-
ficient counseling; (4) the delivery of interventions for smoking cessation by identifying 
smoking patterns.  
2.3.2. ActiGraph GT9X accelerometer 
The ActiGraph GT9X Link (GT9X; ActiGraph Corp, Pensacola, FL, ISA) was used as 
another criterion method for evaluating the validity of the MotionSense HRV in estimat-
ing time spent in sedentary behavior and PA under free-living conditions. ActiGraph is 
the leading manufacturer of research-grade wearable activity monitors; ActiGraph accel-
erometers are most commonly used to examine sedentary behavior and PA in research 
[27-32]. The GT9X is the latest generation of research-grade accelerometer produced by 
ActiGraph. The GT9X is a small and light (3.5 × 3.5 × 1 cm; 14 g) device that can be worn 
on the wrist or at the waist using a manufacturer-provided wrist-strap or belt clip and 
features a tri-axial accelerometer at a dynamic range ± 8 g. The GT9X records vertical, 
anteroposterior, and mediolateral accelerations at a user-selected sampling rate (30–100 
Hz). This device can be used to estimate a user’s PA intensity, activity and sedentary 
bouts, and steps taken at a user-selected epoch length (1–60 seconds) [27,31]. Previous 
studies have determined the validity of GT9X in estimating PA energy expenditure [27,33] 
and activity intensities [12] compared to an indirect calorimetry method, as well as wear-
time detection compared to direct observation and self-reported methods [34]. Addition-
ally, the reliability of the ActiGraph accelerometer for measuring sedentary behavior and 
PA under free-living conditions was confirmed in a previous study (standard error of the 
measurement < 11.2%) [35]. Accordingly, GT9X was previously used as a criterion meas-
ure to investigate the validity of consumer-based activity monitors in estimating PA in 
free-living conditions [36,37]. For that reason, the current study chose GT9X as a criterion 
measure to examine the validity of the MotionSense HRV in estimating time spent in sed-
entary behavior and PA during free-living conditions.  
2.3.3. Indirect Calorimetry 
The Cosmed K5 portable indirect calorimetry system (COSMED, Rome, Italy; K5) 
was used as a criterion measurement of PA during a simulated free-living session. Indirect 
calorimetry is a non-invasive technique that measures respiratory gas exchange to calcu-
late energy expenditure. More specifically, indirect calorimetry measures inspired and ex-
pired gas flows, volumes, and concentrations of oxygen (O2) and carbon dioxide (CO2). 
The expired concentrations of O2 and CO2 can be used to calculate oxygen uptake (VO2) 
and carbon dioxide production (VCO2), which can, in turn, be used to estimate energy 
expenditure [38]. Indirect calorimetry is commonly used to calculate respiratory quotient 
(CO2 production/O2 uptake) and resting energy expenditure, as well as to determine ca-
loric needs in research [39-41]. The K5, our criterion measure, is a portable indirect calo-
rimetry system (174 × 111 × 64 mm and 900 g, including battery and O2 sensor) that is worn 
on the back with a harness [42].  
Generally, portable indirect calorimetry systems are used for measuring maximal ox-
ygen uptake (VO2max) in specific exercise conditions, validating and calibrating accelerom-
eter-based physical activity monitors in the laboratory and free-living conditions (up to 6 
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continuous hours), and calculating physical activity energy expenditure in free-living con-
ditions [42]. Previous studies have determined the validity and the reliability of the K5. 
They showed that the K5’s measurements of metabolic parameters (pulmonary ventila-
tion, oxygen consumption, and carbon dioxide production) were comparable to the meas-
urements from the breath-by-breath method of the traditional metabolic cart (Vyntus 
CPX; Jaeger-CareFusion, Höchberg, Germany), the automated breathing metabolic simu-
lator (VacuMed automated system; VacuMed, USA), and the Douglas Bag Method [42–
44]. Additionally, a recent study reported very high intra- and inter-device reliability of 
the K5 in measuring pulmonary ventilation, oxygen consumption, and carbon dioxide 
production (r > 0.99) [44]. 
Moreover, the K5 has been utilized as a criterion measurement to examine the valid-
ity of wearable activity monitors in estimating activity intensities [45]. The main unit of 
the K5 communicates with the OMNIA Metabolic software (COSMED, Rome, Italy) on a 
computer via Bluetooth and is capable of storing up to 2,048,000 breaths. Prior to the sim-
ulated free-living session, the K5 was calibrated using the manufacturer’s recommenda-
tions: (1) a flow meter calibration using a 3-L syringe, (2) a scrubber calibration that zeros 
the carbon dioxide (CO2) analyzer, (3) a reference gas calibration using a reference gas 
(16% O2, 5% CO2, 79% nitrogen). During the simulated free-living session, we used the 
Breath-by-Breath test mode (measures pulmonary ventilation and gas exchange) to meas-
ure oxygen uptake VO2 (mL·min−1) values [42].  
2.4. Procedures 
Participants visited the University of Utah PA research laboratory on two separate 
occasions (1st visits: free-living session; 2nd visits: simulated free-living session). Upon 
arrival at the PA lab for the 1st visit, the participants completed informed consent and a 
pre-enrollment survey, which gathers sociodemographic information. Research staff 
measured the anthropometric characteristics of each participant using a stadiometer 
(ShorrBoard®, Olney, MD) for height (cm), an electric body-scale (Seca 869, Hamburg, 
Germany) for weight (kg), and a tape measure (Baseline® Evaluation Instruments, White 
Plains, NY, USA) for waist circumference. For the anthropometric measure, the partici-
pants were asked to wear minimal clothing and take off their shoes. Body mass index 
(BMI, kg/m2) was calculated based on the measured height and weight. Research staff 
measured all the anthropometric characteristics three times to avoid any measurement 
error. After the anthropometric measures, participants were fitted with an MotionSense 
HRV device on their non-dominant wrist. Then research staff paired the device with a 
smartphone and the mCelebrum mobile application, where raw acceleration data from 
the sensor were transferred and stored. The sampling rate of the MotionSense HRV was 
25 Hz, which is the default configuration. After fitting the MotionSense HRV, a GT9X de-
vice was initialized with a sampling rate of 100 Hz using ActiLife 6 software (ActiGraph, 
Pensacola, FL, USA). The GT9X device was fitted on the participant’s non-dominant wrist 
using a manufacturer-provided wrist-strap. The GT9X was secured midway between the 
radial and the ulnar styloid processes [12]. Each participant was instructed on how to sim-
ultaneously wear MotionSense HRV and GT9X devices for the next 7 days during all wak-
ing hours except while performing aquatic activities (e.g., bathing or swimming) and 
charging the devices. Additionally, the participants were instructed to record (document) 
their daily sleep times and any non-wear time during waking hours on the sleep and non-
wear time log. 
Once the participants returned to the PA lab after the free-living condition, they first 
asked to complete the post-enrollment survey, which includes 12 questions about usabil-
ity (e.g., the degree of the burden to carry devices and a smartphone, privacy issues, and 
troubleshooting experiences) of the MotionSense HRV during the free-living session. 
Then, participants were explained on the activity protocol for the simulated free-living 
session. During this session, each participant performed the activity protocol for 62 
minutes in the gym. In the activity protocol, a total of 12 activities were categorized into 
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three intensity categories (i.e., sedentary behavior, light PA, and moderate-to-vigorous 
PA) according to the PA compendium [46]. Each activity was selected to simulate activi-
ties that are commonly performed in free-living conditions (Table 1). Following the expla-
nation about the activity protocol, the participant was fitted with the K5 indirect calorim-
etry with a face mask. Additionally, the participant wore the MotionSense HRV and GT9X 
on their non-dominant wrist. Participants performed each activity for 5 minutes and took 
a 1-minute break during the transition between each intensity category. Upon completing 
the entire activity protocol, data collected from the MotionSense HRV, GT9X, and K5 were 
immediately downloaded and securely stored for statistical analyses.  
Table 1. Description of activities by intensity. 
Intensity Type Activity Duration 
Sedentary Behavior 
Resting in the supine position 5 min 
Watching TV in the sitting position 5 min 
Reading books in the sitting position 5 min 
Typing computer in the sitting position 5 min 
Transit #1  1 min 
Light Physical Activity 
Fidgeting in the standing position 5 min 
Walking at a casual pace (1–1.5 mph) 5 min 
Housekeeping/work (i.e., setting the table) 5 min 
Exploring/sorting (i.e., stacking light boxes) 5 min 
Transit #2  1 min 
Moderate-to-Vigorous Physi-
cal Activity  
Walking briskly (2.5–3.0 mph) 5 min 
Running at a moderate pace (3.5–4.0 mph) 5 min 
Running at a fast pace (4.5–5.0 mph)  5 min 
Full body free play (e.g., throwing ball, basketball, 
soccer, tennis, jumping jack) 
5 min 
2.5. Data Processing 
2.5.1. Activity Monitors 
Data from the GT9X and MotionSense HRV were downloaded and saved as their 
raw data format using the ActiLife 6 software and the mCerebrum mobile application, 
respectively, and both types were converted into “.csv” files for further analyses. The R-
package (http://cran.r-project.org) designed for reducing multiday raw acceleration data 
called the GGIR package (version 1.10-10) [47] was used to calculate the amount of time 
spent in sedentary behavior and PA based on the intensity-specific milli-g cut-points de-
rived from previously validated regression equations [48]. More specifically, the GGIR 
package calibrates the raw tri-axial acceleration data and converts it to the Euclidean norm 
minus one (ENMO; x + y + z − 1𝑔). The ENMO indicates the value of gravity with 
negative values rounded to zero [49]. The ENMO values were categorized into different 
activity levels per one-second by applying the intensity thresholds for ENMO derived by 
Hildebrand et al [48, 50]. Following the activity classification, the processed GT9X and 
MotionSense HRV data were merged and aligned into a single dataset. The single activity 
monitor dataset was collapsed into a 60-second epoch data for excluding the non-wear 
and sleep time. Non-wear time and sleep time were defined and excluded in the ActiLife 
software using Choi’s Algorithm [51] and self-reported activity/sleep log from each par-
ticipant. Choi’s Algorithm detects the non-wear time if the accelerometer detects consec-
utive zero counts within a 90-minute window [51]. Additionally, Choi’s Algorithm re-
gards nonzero counts of up to 2 minutes within 30-minute rolling windows of zero counts 
as artifactual accelerometer movements (e.g., the device is accidentally moved on a bed-
side table) during non-wear periods [51]. In addition, given that MotionSense HRV's ac-
celeration data could not be collected at the disconnecting moments with the smartphone, 
the times not recorded MotionSense HRV's data were considered as invalid times in this 
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study. We only included the data with valid time during waking hours of each day for 
statistical analyses. 
2.5.2. Indirect Calorimetry  
Breath-by-breath data from the K5 were exported in a “.csv” format by a 10-second 
epoch. The K5 data were collapsed into a 60-second interval and calculated to the meta-
bolic equivalence of task (MET; 1 MET = 3.5 ml/kg/min) using measured VO2 (ml/min) and 
the body weight (kg) of each participant. Then, the calculated MET were classified into 
different activity levels (≤ 1.5 MET = sedentary behavior, 1.6 - 2.9 MET= Light PA, 3.0 - 5.9 
MET = Moderate PA, ≥ 6.0 MET = Vigorous PA). Following the classification, the processed 
K5 data was merged with a single activity monitor dataset for statistical analyses. 
2.6. Statistical Analysis 
Descriptive analyses were conducted to summarize the sociodemographic and an-
thropometric characteristics of the participants. The normality of data was confirmed us-
ing the Shapiro–Wilk test. Thus, all statistical analyses were performed using parametric 
statistics. Pearson correlation coefficients were used to determine the relationship be-
tween estimates from the MotionSense HRV and those from the GT9X or the K5 indirect 
calorimetry. Measurement errors of the MotionSense HRV in comparison with the crite-
rion measures were calculated based on mean absolute percent errors. Bland–Altman 
plots illustrated the agreement and systematic biases in the estimates of sedentary behav-
ior and PA between the MotionSense HRV and criterion measures. Equivalence testing 
was performed to determine whether sedentary behavior and PA estimates from the Mo-
tionSense HRV are equivalent to those from the GT9X or the K5 indirect calorimetry [52]. 
The 90% confidence interval (CI) of the estimates from the MotionSense HRV were com-
pared with the EZ from the K5 and the GT9X. Since there is no evidence of a universally 
acceptable EZ range, this study established a minimum EZ for the K5 and GT9X measures 
that include 90% CI of the MotionSense HRV estimates. Data were analyzed using the 
Stata 14.2 software and SAS 9.4 software (SAS Institute, Cary, NC, USA), and statistical 
significance was set at p < 0.05. 
3. Results 
The participant characteristics are presented in Table 2. The mean age of participants 
was 32.5 ± 15.1 years. Participants had an average weight of 90.1 ± 12.5 kg, with a BMI of 
30.5 ± 4.0 kg/m2. Moreover, the results of the post-enrollment survey revealed that partic-
ipants were generally acceptive of the smartphone and mCerebrum software and had lit-
tle concerns over data privacy issues. The majority of the participants (i.e., 75%) were will-
ing to use the system for longer-term measurements (Table S1). 
Table 2. Participant characteristics by gender, mean ± standard deviation. 
 All (N = 20) Male (N = 8) Female (N = 12) p-Value * 
Age (years) 32.5 ± 15.1 29.5 ± 13.1 34.5 ± 16.5 0.48 
Height (cm) 172.0 ± 6.9 178.8 ± 2.5 167.5 ± 4.6 <0.01 ** 
Weight (kg) 90.1 ± 12.5 96.1 ± 13.0 86.1 ± 10.9 0.08 
Waist (cm) 97.7 ± 10.9 98.1 ± 13.5 97.5 ± 9.4 0.91 
BMI (kg/m2) 30.5 ± 4.0 30.1 ± 4.3 30.7 ± 4.0 0.74 
Weight Status (%)     
Normal 15% 12.5% 17% 0.78 
Overweight/obese 75% 87.5% 83% 0.78 
Wear time (min/day) 297.7 ± 119.7 318.3 ± 158.9 283.9 ± 90.3 0.54 
* p-value for gender difference; ** p < 0.05. 
We observed very strong correlations for sedentary behavior and PA estimates be-
tween the GT9X and MotionSense HRV (range: r = 0.95 to 0.99, p < 0.01) under free-living 
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conditions (Figure 1). In the simulated free-living conditions, the correlations between the 
K5 and MotionSense HRV were moderate for sedentary behavior (r = 0.51, p = 0.04) and 
total PA (r = 0.38, p = 0.13), weak for moderate-to-vigorous PA (r = 0.28, p = 0.28), and very 
weak for light PA (r = −0.03, p = 0.91; Figure 2).  
 
Figure 1. Pearson Correlations (r) for sedentary behavior and physical activity (PA) estimates be-
tween the GT9X and MotionSense HRV (MSHRV) under free-living conditions. SED: sedentary 
behavior; LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: total PA; * p < 0.05. 
 
Figure 2. Pearson Correlations (r) for sedentary behavior and physical activity (PA) estimates be-
tween the Cosmed K5 (K5) and MotionSense HRV (MSHRV) under simulated free-living condi-
tions. SED: sedentary behavior; LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: total PA; * 
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Overall, the mean differences in activity estimates across varying intensities were rel-
atively small between the GT9X and MotionSense HRV (mean difference range: −5.7–5.7 
min/day; mean absolute present error range: 2.4–9.1%) in the free-living conditions (Table 
3). In the simulated free-living conditions, the mean differences in sedentary behavior and 
PA estimates between the Cosmed K5 and MotionSense HRV ranged from −4.1 min to 6.8 
min; the mean absolute present error of MotionSense HRV in estimating sedentary behav-
ior and PA ranged from 12.3% to 44.2% (Table 4).  
Table 3. Mean differences (SE) and Mean Absolute Percent Errors of Sedentary behavior and 
Physical activity (PA) between the GT9X and MotionSense HRV under free-living conditions. 
Intensity GT9X (SD) MotionSense HRV (SD) Mean diff. (SE) MAPE (%) 
SED 237.1 min (97.8) 242.8 min (99.5) −5.7 min (1.7) 2.4% 
LPA 38.6 min (15.8) 35.3 min (14.8) 3.3 min (1.1) 8.7% 
MVPA 26.4 min (16.2) 24.0 min (15.1) 2.4 min (0.8) 9.1% 
TPA 65.0 min (29.3) 59.2 min (27.2) 5.7 min (1.7) 8.8% 
MAPE: Mean Absolute Percent Error; SD: standard deviation; SE: Standard Error; SED: sedentary behavior; 
LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: total PA. 
Table 4. Mean differences (SE) and Mean Absolute Percent Errors of Sedentary behavior and 
Physical activity (PA) between the Cosmed K5 and MotionSense HRV under simulated free-living 
condition. 
Intensity Cosmed K5 (SD) MotionSense HRV (SD) Mean diff. (SE) MAPE (%) 
SED 21.6 min (4.2) 25.7 min (2.6) −4.1 min (0.9) 18.9% 
LPA 15.3 min (2.7) 8.5 min (1.6) 6.8 min (0.8) 44.2% 
MVPA 17.5 min (3.8) 19.6 min (2.4) −2.1 min (0.9) 12.3% 
TPA 32.8 min (3.9) 28.2 min (2.6) 4.6 min (0.9) 14.1% 
MAPE: Mean Absolute Percent Error; SD: standard deviation; SE: Standard Error; SED: sedentary behavior; 
LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: total PA. 
The results from the Bland–Altman plots showed that there was no apparent bias for 
the agreement in sedentary behavior and PA estimates between the MotionSense HRV 
and GT9X under free-living conditions (Figure 3); however, the results from the simulated 
free-living condition revealed that the MotionSense HRV tends to provide lower light PA 
estimates compared to the K5 (Figure 4). 
The results of the equivalent tests are shown in Tables 5 and 6. The estimates from 
the MotionSense HRV were equivalent to those from GT9X when the equivalence zones 
were set at 16.5% for sedentary behavior, 23.6% for light PA, 29% for moderate-to-vigor-
ous PA, and 24.1% for total PA (Table 5). Under the simulated free-living conditions, the 
estimates from the MotionSense HRV reached equivalence when the equivalence zones of 
the K5 were set at 24.1% for sedentary behavior, 48.6% for light PA, 18.2% for moderate-
to-vigorous PA, and 17.5% for total PA (Table 6). 




Figure 3. Bland–Altman plots illustrating the level of agreement in sedentary behavior and PA 
estimates between the GT9X and MotionSense HRV (MSHRV) under free-living conditions. 
Dashed lines show 95% limits of agreement (± 1.96 standard deviation). SED: sedentary behavior; 
LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: total PA. 
 
Figure 4. Bland–Altman plots illustrating the level of agreement in sedentary behavior and PA 
estimates between the Cosmed K5 and MotionSense HRV (MSHRV) under simulated free-liv-
ing conditions. Dashed lines show 95% limits of agreement (± 1.96 standard deviation). SED: 
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Table 5. 90% Confidence Intervals (CIs) from the MotionSense HRV and Equivalence Zones (EZs) 
from the GT9X in free-living conditions. 
Intensity GT9X (SE) 
MotionSense HRV 
(SE) 
90% CI of  
MotionSense HRV 
EZ of  
GT9X EZ (%) 
SED 237.1 min (4.2) 242.8 min (22.4) 198.18 to 275.7 min/d 197.98 to 276.2 min/d 16.5% 
LPA 38.6 min (3.6) 35.3 min (3.2) 29.51 to 40.7 min/d 29.49 to 47.71 min/d 23.6% 
MVPA 26.4 min (3.7) 24.0 min (3.3) 18.74 to 30.28 min/d 18.72 to 34.01 min/d 29.0% 
TPA 65.0 min (6.7) 59.2 min (5.9) 49.35 to 69.87 min/d 49.31 to 80.62 min/d 24.1% 
SE: standard error; SED: sedentary behavior; LPA: light PA; MVPA: moderate-to-vigorous PA; 
TPA: total PA. 
Table 6. 90% Confidence Intervals (CIs) from the MotionSense HRV and Equivalence Zones (EZs) 
from the K5 indirect calorimetry in simulated free-living conditions. 




90% CI of  
MotionSense HRV 
EZ of  
Cosmed K5 
EZ (%) 
SED 21.6 min (4.2) 25.7 min (2.6) 24.64 to 26.85 min/d 16.43 to 26.86 min/d 24.1% 
LPA 15.3 min (2.7) 8.5 min (1.6) 7.88 to 9.2 min/d 7.86 to 22.73 min/d 48.6% 
MVPA 17.5 min (3.8) 19.6 min (2.4) 18.60 to 20.63 min/d 14.29 to 20.65 min/d 18.2% 
TPA 32.8 min (3.9) 28.2 min (2.6) 27.06 to 29.25 min/d 27.03 to 38.5 min/d 17.5% 
SE: standard error; SED: sedentary behavior; LPA: light PA; MVPA: moderate-to-vigorous PA; TPA: 
total PA. 
4. Discussion 
The current study evaluated the concurrent validity of the MotionSense HRV for es-
timating time engaged in sedentary behavior and PA against two previously established 
criterion measures. Our overall findings indicated that the MotionSense HRV can provide 
reasonably comparable measures of time spent in sedentary behavior and different PA 
intensities in comparison to the GT9X, which is the most widely accepted objective 
method for PA measurement in free-living conditions [53,54]. However, the estimates 
from the MotionSense HRV were less comparable when compared with those from K5 
indirect calorimetry during simulated free-living conditions. More specifically, the Mo-
tionSense HRV tends to overestimate sedentary behavior and moderate-to-vigorous PA 
but underestimate light PA and total PA. These specific findings would be valuable to 
researchers and clinicians considering using the MotionSense HRV for comprehensively 
evaluating various health-related behaviors in a large population. 
Findings in free-living conditions demonstrated that the actual mean differences (-
5.7–5.7 min/day) and the mean absolute percent errors (2.4–9.1%) were relatively small 
between the MotionSense HRV and GT9X, suggesting that the MotionSense HRV has 
promising potential to accurately assess sedentary behavior and PA patterns under true 
free-living conditions. The mean bias and mean absolute percent error values provide a 
valuable indicator to determine if the MotionSense HRV accurately estimates sedentary 
behavior and PA patterns. Although it is challenging to directly compare our results with 
other studies due to the absence of published data, the observed mean absolute percent 
errors of the MotionSense HRV against GT9X across sedentary behavior and PA estimates 
can be compared with previous studies that assessed the accuracy of activity monitors 
compared to the ActiGraph in free-living conditions. In general, studies that used the Acti-
Graph as a criterion measure under free-living conditions indicated that the mean abso-
lute percent error of 15% or less is an acceptable degree of error for sedentary behavior 
and PA estimates [55-57]. In light of the relatively low mean absolute percent error values, 
the present study indicated that the MotionSense HRV had a high accuracy across the 
activity intensity classification. Moreover, these results can be interpreted against previ-
ous validation studies that compared the outcomes between devices worn at different 
body locations (e.g., hip, wrist, or ankle) [54, 58]. It has been reported that the accelerom-
eter performance may vary with the device placement site [59–61] suggesting that the va-
lidity determined between the devices worn at different body site could be limited. Unlike 
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those studies, our study directly compared the SED and PA estimates between the Mo-
tionSense HRV and GT9X, as both devices were placed on the same wrist and used for the 
same data processing algorithm using raw acceleration signals [58,62]. Due to the ob-
served agreements for sedentary behavior and PA estimates between the MotionSense 
HRV and GT9X, the MotionSense HRV can be considered a valid device to measure the 
total spectrum of activity, including sedentary behavior and all PA intensities [63].  
It is worth noting that the measurement errors in sedentary behavior and light PA 
were greater for the comparison with the indirect calorimetry than the GT9X. More spe-
cifically, the MotionSense HRV showed a large degree of underestimation for light PA 
relative to the K5 indirect calorimetry, indicating that light PA could be misclassified as 
either sedentary behavior or moderate PA. One possible explanation for the observed dif-
ference in the light PA estimate could be due to the limited number of activities prescribed 
at light intensity levels in the simulated free-living conditions. It is also speculated that 
some participants might have relatively low or high magnitudes of wrist movement when 
standing or performing certain activities for a short duration within light PA under the 
simulated free-living condition. Since the estimations of sedentary behavior and PA were 
based on the amount of wrist acceleration measured by the MotionSense HRV, the degree 
of wrist movements at the prescribed light PA might directly influence the magnitude of 
wrist acceleration measured by the MotionSense HRV. A previous study using the Acti-
Graph accelerometer demonstrated that the locomotive movements could be considered 
as sedentary behavior since the magnitude of wrist acceleration while standing corre-
sponds to that of acceleration during sedentary activities in the lab-based activity protocol 
[48]. Accordingly, the MotionSense HRV may record low acceleration signals during lo-
comotive activities involving limited arm movements, thus misclassifying light PA as sed-
entary behavior while performing the prescribed activities during the simulated free-liv-
ing conditions. Likewise, the magnitude of wrist acceleration during a certain light PA 
with a lot of wrist movements might exceed the threshold for the light PA, resulting in the 
MotionSense HRV underestimating the light PA time. Consequently, our findings may 
suggest that the MotionSense HRV may not be an ideal device to measure activity esti-
mates or energy expenditure for light PA in laboratory-based settings or a short period of 
time. Nonetheless, given that people use various arm movements even when standing in 
true free-living conditions, the MotionSense HRV is still an acceptable measurement tool 
to estimate the time spent in sedentary behavior and PA for clinical and research pur-
poses. 
In the present study, we examined the MotionSense HRV’s accuracy at both the in-
dividual and group level. Evaluating the degree of systematic error at the individual level 
may be more stringent because, unlike the measurement at the group level, the measure-
ment errors may not be offset by the larger sample at the individual level [64]. The results 
from the Bland–Altman plots across all activity intensities showed that the mean biases in 
the estimates between MotionSense HRV and GT9X were small, and only one individual 
bias fell outside of the 95% limits of agreement. These findings suggest that the Motion-
Sense HRV yielded relatively precise SED and PA estimates compared to the GT9X at the 
individual level under free-living conditions [64,65]. Moreover, we used equivalence test-
ing to directly assess agreement between the MotionSense HRV and criterion measures at 
the group level [52,66]. Due to the absence of a universally acceptable equivalence zone 
range, the current study attempted to examine the relative equivalency, which is actual 
equivalence zone of the MotionSense HRV against the criterion measures, instead of de-
termining the equivalence of the MotionSense HRV in a dichotomous manner by setting 
a priori a specific zone of equivalence [64]. Additionally, equivalence testing was a rigor-
ous analytic method to assess agreement for the MotionSense HRV against the criterion 
measures, so it would not be used alone to define the agreement. Instead, it facilitated the 
evaluation of systematic error with other analytic methods, such as mean absolute present 
error and Bland–Altman plot. Using this approach, we were able to identify the actual 
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equivalence regions where the 90% confidence intervals of the estimates from the Motion-
Sense HRV completely fall within the mean estimates from the criterion measures. These 
findings also demonstrated that the MotionSense HRV had a relatively low measurement 
error at the group level in estimating sedentary behavior compared to light PA and mod-
erate-to-vigorous PA under free-living conditions, supporting the results of other statisti-
cal analyses in this study. Thus, the findings from the equivalence testing could help re-
searchers and clinicians to make more informed decisions on the validity of the Motion-
Sense HRV for future use in research and in practical settings.  
With the ever-increasing interest in mobile health (mHealth), the utility of a wearable 
device for monitoring various physiological and behavioral factors influencing health 
conditions is an essential component of the mHealth system [3]. The MotionSense HRV, a 
wrist-worn mHealth device, is capable of measuring hand gestures and bodily move-
ments via accelerometers and gyroscopes and interbeat intervals via PPG sensors [5]. In 
addition, the MotionSense HRV could provide more efficiency in data management than 
using multiple sensors measuring individual factors, because it is compatible with the 
mCerebrum mobile application that enables processing data from multiple sensors in an 
integrated way [5,17]. Notably, the data from the MotionSense HRV can be used to ana-
lyze activity patterns, stress, smoking events, and eating habits through specific algo-
rithms within the mCerebrum [5,8,14,15]. Moreover, the mCerebrum mobile application 
supports data quality assessment and privacy management for sensor and self-report data 
collected by participants in both lab and field settings and wirelessly transmits the pro-
cessed data to a cloud platform (called Cerebral Cortex) [5], allowing clinicians and re-
searchers to use various biological and behavioral data just in time [3,5,17]. Therefore, the 
MotionSense HRV would be a useful mHealth device to accurately and comprehensively 
evaluate users' various health-related behaviors along with PA patterns for patient-cen-
tered lifestyle change intervention and large-scale epidemiologic studies [17,67].  
It is also noteworthy that the MotionSense HRV has great potential for improving its 
accuracy by integrating the data from other equipped sensors such as a 3-axis gyroscope 
and the photoplethysmogram (PPG) sensor, which can measure the angular motion, force, 
and orientation of the body in three dimensions and heart rate (HR) [68, 69]. Indeed, a 
recent study reported that the combined use of gyroscope and accelerometer data in the 
wrist-worn ActiGraph GT9X reduced the measurement error in estimating moderate-to-
vigorous PA compared with the estimates derived from accelerometry data alone [27]. 
This suggests that, along with the MotionSense HRV’s primary three-axis accelerometer, 
the use of multiple sensors together can improve the accuracy of measuring PA, as they 
allow one to measure very comprehensive and sophisticated bodily movements [70]. An-
other significant enhancement that the MotionSense HRV has over other accelerometer-
only devices is the availability of a PPG sensor, which can measure HR [5,71]. Given the 
direct relationship between activity intensity and HR, adding HR data to the accelerome-
try-only algorithm has been shown to increase the device’s accuracy for estimating the 
amount and intensity of PA that particularly involved fewer arm movements (e.g., lower 
body dominant resistance exercise) [72,73]. An additional unique feature of the Motion-
Sense HRV is GPS data capability. Compatible with smartphones, the smartphone’s GPS 
data can be synced with the data from the MotionSense HRV unit and then processed 
together via a mobile application installed on the smartphone called mCerebrum. Adding 
GPS data into the accelerometer-only algorithms could significantly improve the quality 
of the measurements, as it can incorporate rich information, including grades and loca-
tions, which particularly improve assessing PA performed outdoors. Although algo-
rithms that incorporate all the data from multiple sensors and GPS has not been developed 
and thus the validity of these additional features in estimating PA was untestable in the 
present study, the MotionSense HRV has tremendous potential to improve its validity and 
usability further when the utility of its additional sensors in measuring PA is determined 
in subsequent research.  
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This study has strengths that should be highlighted. We assessed the validity of the 
MotionSense HRV comprehensively in both lab-based and free-living conditions using 
high-quality criterion measures [42–44,64,74]. Moreover, we measured PA in free-living 
conditions for more than seven days, including at least one weekend day, in order to en-
sure a high reliability of PA measurement [75]. This approach was critical for determining 
the validity of MotionSense HRV against GT9X because the longer measurement period 
in this study provided more representative measures of habitual PA during free-living 
conditions [75,76] compared to other recent studies that determined the validity of accel-
erometers based on only 1–2 days of measurement [62,77].  
This study also has limitations that are worth mentioning. Our sample consisted of 
Pacific Islanders and was relatively small in size, which may limit the generalizability of 
the findings from this study. However, the observed PA pattern in our sample (24–26 
min/day of moderate-to-vigorous PA) was not significantly different from that in gener-
ally healthy populations; thus, the ethnic characteristics of our sample should not be con-
sidered as a major threat to internal validity in this study. Another limitation of this study 
was that basal metabolic rate (BMR) was not measured during the lab session. Although 
using the true BMR rather than resting metabolic rate is more desirable for estimating 
MET values, the BMR test requires a significant participant burden (i.e., 12-hour fasting) 
as well as exclusive lab settings (i.e., sleep lab), which was not feasible for the present 
study. Lastly, this study could not measure aquatic activities performed during free-living 
conditions because the MotionSense HRV is not completely waterproof.  
5. Conclusions 
The MotionSense HRV can provide reasonably valid sedentary behavior and PA es-
timates in relation to the GT9X in free-living conditions. Relative to the K5 indirect calo-
rimetry, however, we found that the MotionSense HRV had sizable measurement errors 
for sedentary behavior in lab-based and/or short-term research. Considering the accuracy 
of MotionSense HRV's sedentary behavior and PA estimates under free-living conditions, 
we confirmed the promising potential of using MotionSense HRV alone to monitor a va-
riety of health-related behaviors, including PA patterns, stress response, smoking events, 
and eating habits, for research and clinical purposes. Accordingly, this study suggests that 
the developers of the MotionSense HRV should consider adding specific algorithms that 
measure the user's daily sedentary behavior and PA patterns using the internal sensors of 
the MotionSense HRV. 
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